House panel chief demands accountability from US FDA on J&J plant bumbles
This article was originally published in Scrip
Executive Summary
Following through on his pledge to make the US FDA his main target for investigations and "hundreds" of hearings, Representative Darrel Issa (Republican-California), chairman of the US House Oversight and Government Reform Committee, again demanded accountability from the agency, this time for its failure to oversee a Puerto Rican plant at the center of numerous recalls of defective drugs made by Johnson & Johnson's McNeil Consumer Healthcare division.